IP Archives of Cytology and Histopathology Research

Print ISSN: 2581-5725

Online ISSN: 2456-9267

CODEN : IACHCL

IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...

Article type

Case Report


Article page

272-274


Authors Details

Sri Devi R*, Shruthi Kareddy, Soumya B M, Vardendra Kulkarni


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 356

PDF Downloaded: 131


The worst of both worlds - carcinosarcoma of the ovary: A case report


Case Report

Author Details : Sri Devi R*, Shruthi Kareddy, Soumya B M, Vardendra Kulkarni

Volume : 7, Issue : 4, Year : 2022

Article Page : 272-274

https://doi.org/10.18231/j.achr.2022.063



Suggest article by email

Get Permission

Abstract

Ovarian carcinosarcoma (OCS) is a rare, highly aggressive neoplasm characterized by presence of both carcinomatous and sarcomatous component. Even after evolution of chemotherapy with introduction of platinum agents, the survival still seems to be poor. A report of such rare case tumour in a 62 year old female is presented here.
 

Keywords: Ovarian carcinosarcoma, Tumour


How to cite : Sri Devi R, Kareddy S, Soumya B M, Kulkarni V, The worst of both worlds - carcinosarcoma of the ovary: A case report. IP Arch Cytol Histopathol Res 2022;7(4):272-274

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.